Hüseyin Engin

Hüseyin Engin

Auto-generated profile, based on publicly available information

Hüseyin Engin

Bulent Ecevit University School of Medicine Department of Medical Oncology, Zonguldak, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
HEHuseyin Engin
Huseyin Engin
CBCemil Bilir
Cemil Bilir
HUHasan Ustun
Hasan Ustun
AGAyla Gokmen
Ayla Gokmen
ABO Blood Group and Risk of Pancreatic Cancer in a Turkish Population in Western Blacksea Region Blood group;pancreatic cancer;survival;Turkey; Background: We aimed to investigate the relationship between blood groups and pancreatic cancer in a Turkish population in Western Blacksea region. Methods: This is a retrospective study. Zonguldak Karaelmas University outpatient oncology clinic records were screened for the period between 2004 and 2011. Results: The median age of patients were 56 (${\pm}16$) and 132 of 633 study population had pancreatic cancer. Pancreatic cancer patients had significantly higher rates of blood group A compared to controls (OR 1.8, 95%CI, p 0.005). Rates of blood group AB was significantly lower than the control group (OR 0.37, 95% CI, p 0.04). The median survival (IR) time in subjects having the blood groups A, B, AB and O were 7.0 (1-28), 7.0 (2-38), 10 (2-36) and 9.0 (2-48) months respectively; the blood group 0 had significantly higher overall survival (OS) compared to the non-0 groups (p 0.04). Conclusions: Pancreatic cancer patients had more common blood group A in our population. Moreover, blood group AB appeared to be a protective factor against pancreatic cancer in our population. Blood group 0 had a significantly longer survival compared to non-0, regardless of prognostic factors.

1 June 2012 in European Cytokine Network
Verified
Journal Article
Closed access
HEHüseyin Engin
Hüseyin Engin
YÜYücel Üstündağ
Yücel Üstündağ
ITİsHak Özel Tekin
İsHak Özel Tekin
AGAyla Gökmen
Ayla Gökmen
ŞEŞehmuz Ertop
Şehmuz Ertop
SISevil Uygun İlIkhan
Sevil Uygun İlIkhan
Despite the rapidly accumulating histopathological data reporting differences in the expression of members of the angiopoietin family on the surface of various normal and tumour cells, data for these growth factors in plasma from cancer patients, including colon cancer, are scarce. The aims of the present study were to measure the plasma concentrations of Ang-1, Ang-2 and Tie-2 in colon cancer patients, and to assess the correlation between the concentrations of these factors and the stage of the tumor. the study cohort included 36 patients (18 male, 18 female) with colon cancer (mean age 52.6 ± 15.0), and 36 sex- and age-matched, healthy controls who were free of inflammatory, neoplastic, atherosclerotic and connective tissue disease, recruited from hospital staff and attendees at hospital for check-up. Concentrations of Ang-1, Ang-2 and Tie-2 were measured using the enzyme-linked immunosorbent assay (ELISA) method. concentrations of Ang-2 (median 3,188.0 pg/mL, min: 1,070.5-max: 5,765.5) and Tie-2 (median 22 ng/mL, min:12-max:46) were significantly higher in patients with colon cancer, while concentrations of Ang-1 were not statistically different between the groups. Furthermore, concentrations of Ang-2 (median 4,292.0 pg/mL, min: 3,090.0-max: 5,765.5) were found to be significantly higher in stage III patients compared to stage II patients, whereas no difference was found between the concentrations of Ang-1 and Tie-2 in different colon cancer stages. plasma concentrations of Ang-1, Ang-2 and Tie-2 may be valuable, additional, tumor markers in colon cancer that should be tested in further trials.

1 May 2004 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MKMevlüt Kurt
Mevlüt Kurt
OEOrhan Önder Eren
Orhan Önder Eren
HEHüseyin Engin
Hüseyin Engin
NGNilüfer Güler
Nilüfer Güler

1 March 2012 in European Cytokine Network
Verified
Journal Article
Closed access
HEHüseyin Engin
Hüseyin Engin
YÜYücel Üstündağ
Yücel Üstündağ
ITİsHak Özel Tekin
İsHak Özel Tekin
AGAyla Gökmen
Ayla Gökmen
Ang-1 and Ang-2 have both been identified as ligands for Tie-2, a receptor expressed on endothelial cells (EC). They play critical roles in angiogenesis, in concert with VEGF. Ang-1-binding to Tie-2 maintains and stabilizes mature vessels by promoting interactions between EC and the surrounding extra-cellular matrix. However, Ang-2 shows context-dependent, proangiogenic and antiangiogenic activities. Despite the rapidly accumulating histopathological data reporting differences in the expression of members of the Ang family on the surface of various normal and tumour cells, data for these growth factors in plasma from cancer patients, including gastric cancer, remain scarce. The aims of the present study were to measure the plasma concentrations of Ang-1, Ang-2 and Tie-2 in gastric cancer patients, and to assess the correlation between the concentrations of these factors and the stage of the tumor. The study cohort consisted of 50 patients (33 male, 17 female) with gastric cancer, ranging in age from 38 to 74 years (mean age 55.3±12.4), and 50 sex- and age-matched, healthy controls. Determinations of Ang-1, Ang-2 and Tie-2 were performed using the enzyme-linked immunosorbent assay (ELISA) method. Concentrations of Ang-2 and Tie-2 were significantly higher in patients with gastric cancer than controls, while concentrations of Ang-1 were not statistically different between the groups. Concentrations of Ang-1, Ang-2 and Tie-2 were not statistically significantly different in gastric cancer patients with different stages of disease. Ang-2 and Tie-2 plasma concentrations might be useful, additional tumor markers in gastric cancer.

1 February 2006
Verified
Journal Article
Closed access
HEHüseyin Engin
Hüseyin Engin
EBEsmen Baltali
Esmen Baltali
NGNilüfer Güler
Nilüfer Güler
GGGülnur Güler
Gülnur Güler
GTGülten Tekuzman
Gülten Tekuzman
AUAysegül Uner
Aysegül Uner

12 December 2015 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Open access
PDF file
SESehmus Ertop
Sehmus Ertop
MBMuammer Bilici
Muammer Bilici
HEHuseyin Engin
Huseyin Engin
CBCagatay Buyukuysal
Cagatay Buyukuysal
MAMuzeyyen Arslaner
Muzeyyen Arslaner
ITIshak Ozel Tekin
Ishak Ozel Tekin
Venous thromboembolism (VTE) is generally classified as provoked or unprovoked. This dichotomy is important for following patients, mortality rate, prognosis and whether more efficient therapy is needed. In VTE patients, during initial diagnosis, it is not known exactly whether red cell distribution width (RDW) have a predictable value for this differentiation and pathogenesis. In this study, 298 patients with VTE and 197 control subjects were included. Patients with VTE were defined as provoked or unprovoked with respect to physical examination findings and laboratory values. Changes in RDW were tested between VTE patients and control subjects, provoked and unprovoked VTE patients, and separately with control subjects. RDW was found to be high in provoked and unprovoked groups compared with control group (p < 0.001, p = 0.003 respectively). RDW was significantly high in provoked VTE patients group compared with unprovoked patients (p < 0.001) and a cut-off value was found to be 13.6 %. In ROC analysis, sensitivity was 90.19 % and specificity was 82 % (95 % CI 85.4–93. 8 % and 95 % CI 72.3–89. 6 % respectively). RDW could be used as a simple, costeffective and a reliable test independent of age in differentiation of provoked and unprovoked VTE. In order to better understand its role, prospective large homogenized population studies in different regions are necessary.